Molecular Tumor Board: Breast Cancer, Large Cell Neuroendocrine Carcinoma of the Lung, Sinonasal Undifferentiated Carcinoma of the Head & Neck, and Adenocarcinoma of the Lung

Molecular Tumor Board: Breast Cancer, Large Cell Neuroendocrine Carcinoma of the Lung, Sinonasal Undifferentiated Carcinoma of the Head & Neck, and Adenocarcinoma of the Lung is organized by Cancer Treatment Centers of America® (CTCA).

Released: Jun 04, 2019
Expires: Dec 05, 2019

Intended Audience:
Physicians or other clinicians who particpate in molecular tumor boards.

Maximum Credits:
1.00 / AMA PRA Category 1 Credit™.

Description:
A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic testing, pathology and radiological imaging. Cases discussed include: breast cancer, large cell neuroendocrine carcinoma of the lung, sinonasal undifferentiated carcinoma of the head & neck and adenocarcinoma of the lung.

Educational Objectives:
Upon completion of this activity, participants will be able to:
• Utilize skills learned to implement an effective tumor board.
• Describe genomic testing.
• Implement genomic profiling into oncology treatment.